# Tool Compounds to Probe Multispecies Biofilms in the Human Oral Microbiome

> **NIH NIH R01** · EMORY UNIVERSITY · 2020 · $362,362

## Abstract

Project Summary
 The proposed research will interrogate the natural product scaffold of carolacton as a starting point
for agents that perturb S. mutans (SMU) biofilms. Carolacton is remarkable: instead of dispersing
established biofilms or killing planktonic cells, carolacton targets cells transitioning into the biofilm state,
and it is effective at very low concentrations. Here we present a multi-faceted approach, including
organic synthesis, molecular genetics, proteomics, transcriptomics, and microbiological assays that
begins with carolacton but has as an overarching goal the development of tool compounds that can be
used to understand SMU biofilm processes within a multispecies environment.
 The first specific aim seeks to identify the specific target(s) of carolacton and a recently discovered
analog that also has profound effects on SMU biofilms. This approach will employ genetic,
transcriptomic, and MS-proteomic techniques to identify candidates that bind carolacton, from which we
will confirm the targets using biochemical studies. This will shed light on the processes that the natural
product affects and allow for a broader evaluation of the target in general biofilm processes.
 The second specific aim involves the chemical synthesis of rationally designed compounds related
to carolacton. Proposed compounds will focus on four main aspects: 1) obtaining a detailed structure-
activity relationship understanding of the carolacton structure; 2) determining the minimally complex
scaffold that retains biological activity; 3) improving the physiochemical properties; and 4) identification
of a lead compound for use in dental composites. Central to the efficient and concise strategies
proposed is the knowledge gained in our previously described total synthesis.
 The third aim will investigate the biological properties of the tool compounds both in single species
and multispecies biofilms. Preliminary results have identified that both carolacton and a newly
synthesized analog cause a unique and specific phenotypic response to S. mutans biofilms. Therefore,
all analogs will be tested against both planktonic and biofilm cells with S. mutans UA159 using confocal
microscopy. Lead compounds will then be analyzed in assays with clinical isolates of both S. mutans
and other bacteria involved in dental caries in collaboration with the Univ. of Rochester and the Univ. of
Florida. Concurrently, compounds will be evaluated in mixed-species biofilms between S. mutans and
commensal bacteria (i.e. S. sanguinis, S. gordonii) to identify pathogen-specific inhibitors. Previous
work has demonstrated that oral pathogens with compromised signaling systems are reduced viability
in the presence of commensal bacteria and we intend to build on this earlier work.

## Key facts

- **NIH application ID:** 9976994
- **Project number:** 5R01DE025837-05
- **Recipient organization:** EMORY UNIVERSITY
- **Principal Investigator:** William M Wuest
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $362,362
- **Award type:** 5
- **Project period:** 2017-08-01 → 2021-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9976994

## Citation

> US National Institutes of Health, RePORTER application 9976994, Tool Compounds to Probe Multispecies Biofilms in the Human Oral Microbiome (5R01DE025837-05). Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/grant/nih/9976994. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*